Pharm
Diltiazem
search
Diltiazem
, Cardizem, Benzothiazapine, Cartia, Taztia, Tiazac
See Also
Calcium Channel Blocker
Calcium Channel Blocker Overdose
Dihydropyridine Calcium Channel Blocker
(e.g.
Amlodipine
,
Nifedipine
)
Verapamil
Mibefradil
Precautions
Write for generic Diltiazem ER to allow pharmacist to substitute between multiple similar ER preparations
(2016) Presc Lett 23(7): 39-40
Mechanism
Non-Dihydropyridine Calcium Channel Blocker
AV Node
effects
Slow
AV Node
Conduction
Prolong
AV Node
refractory period
Less negative hemodynamic effects than
Verapamil
Potent negative chronotropic effect with decreased
Heart Rate
(but less than with
Verapamil
)
Minimal negative inotropic effect
Decreases
Afterload
via peripheral arterial vasodilation
Diltiazem affects
Left Ventricular Dysfunction
less than
Verapamil
Coronary vasodilatation
Prevents sympathetic induced
Coronary Artery
spasm
May reduce
Angina
l episodes and increase
Exercise
tolerance in
Stable Angina
Indications
Hypertension
Consider
Dihydropyridine Calcium Channel Blocker
(e.g.
Amlodipine
) instead if
Heart Rate
control not needed
Atrial Fibrillation with Rapid Ventricular Response
Highly effective at controlling ventricular rate
Paroxysmal Supraventricular Tachycardia
Less studied than
Verapamil
for
PSVT
Supraventricular Tachycardia
Terminates
AV Node
reentry
Tachycardia
s
Contraindications
Wolff-Parkinson-White Syndrome
with
Atrial Fibrillation
Paroxysmal accelerated ventricular response
Risk of progression into
Ventricular Fibrillation
Wide Complex Tachycardia
(unless supraventricular)
Risk of severe
Hypotension
May progress into
Ventricular Fibrillation
Sinus Node or
AV Node
dysfunction without
Pacemaker
AV Block
Sick Sinus Syndrome
Severe
Congestive Heart Failure
or pulmonary congestion
Concurrent Intravenous
Beta Blocker
use
Hypotension
Dosing
Rapid
Atrial Fibrillation
or
PSVT
Regimen 1: One Bolus and then maintenance
Bolus: 0.25 mg/kg (to 20 mg) IV over 2 minutes
Maintenance: 10 mg/hour titrated to
Heart Rate
(typically 5-15 mg/hour)
Mnemonic: Rule of 15 for patient weight of 70 kg
First: 15 mg IV over 2 minutes, then infusion at 15 mg/hour
Titrate dosing between 5 to 15 mg/hour
Regimen 2: Two boluses and then maintenance
Bolus One: 0.25 mg/kg (to 20 mg) IV over 2 minutes
Bolus Two: 0.35 mg/kg (to 25 mg) IV over 2 minutes starting 15 minutes after first bolus
Maintenance: 10 mg/hour titrated to
Heart Rate
(typically 5-15 mg/hour)
Regimen 3: Hypotensive patient
"Bolus": 2.5 mg/min over 10-20 min infusion
http://ehced.org/wp-content/site/Drips/dilt-load.pdf
Maintenance: 5 mg/hour titrated as
Blood Pressure
allows to
Heart Rate
(typically 5-15 mg/hour)
Pretreating with
Calcium
is unlikely to benefit
Blood Pressure
At best may offer transient
Blood Pressure
increase for 10 minutes (secondary to
Catecholamine
surge)
Calcium
infusion could be considered in
Hypocalcemia
(e.g.
Calcium Chloride
0.5 to 1 g IV)
Kolkebeck (2004) J Emerg Med 26(4): 395-400 [PubMed]
Oral dosing after intravenous rate control
Consider switching to
Beta Blocker
for chronic rate control (more efficacious than oral Diltiazem)
Diltiazem regular release starting at 30-60 mg orally three to four times daily
Titrate 120 to 360 mg orally daily with extended release
Dosing
Hypertension
in Adults
Regular Release
Start 30 mg orally three times times daily
Maximum 360 mg/day
Extended Release
Long-acting formulations have variable release mechanisms and dosing regimens vary between products
Extended Release (XR, XT, CD) formulations are dosed once daily
Sustained Release (SR) formulations are dosed twice daily
Extended release capsule contents may be sprinkled on food
Start 120-240 mg orally daily
Target: 240 to 360 mg/day
Maximum: 540 mg/day
Dosing
Hypertension in Children
(Not FDA approved)
Regular Release
Start 1.5 to 2 mg/kg/day orally divided 3 to 4 times daily
Maximum 3.5 mg/kg/day
Adverse Effects
See
Calcium Channel Blocker
Peripheral Edema
Dizziness
Headache
Nausea
Rash
Asthenia
Bradycardia
Pharmacokinetics
Onset in 2-7 minutes after IV infusion
Bioavailability
50% after oral dose
Protein
bound 75%
Half-Life
3 hours with active metabolites
Metabolism
Decrease dose in renal disease
Accumulation risk with liver
Impairment
Drug Interactions
Agents that prolong
AV Node
conduction (avoid)
Beta Blocker
s
Digoxin
Clonidine
(case reports of severe episodes)
Ivabradine
(contraindicated in combination)
Agents that have levels increased by Diltiazem
Propranolol
Buspirone
Lovastatin
(limit to 20 mg daily)
Simvastatin
(limit to 10 mg daily)
Quinidine
Agents that increase Diltiazem Levels
Cimetidine
Safety
Pregnancy Category C
Safe in
Lactation
Resources
Diltiazem Tablet Extended Release (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56573e9d-7bd2-694c-cd6d-26039590e548
Diltiazem Injection Solution (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e36488b-8f2d-4dc9-b803-af1829e6fdd0
References
(2022) Presc Lett 29(11): 64-5
(2022) Presc Lett, Resource #381108, Comparison of
Calcium Channel Blocker
s
(2020) Med Lett Drugs Ther 62(1598): 73-80
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 70-1
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here